Showing results (2011-2020 of 4,138) with videos related to
Sort By:
Pageof 414
Human Gene Therapy|January 31, 2008
Overcoming the innate immune response to small interfering RNAAdam Judge, Ian MacLachlanHuman Gene Therapy|June 17, 2015
The Bacterial Origins of the CRISPR Genome-Editing RevolutionErik J Sontheimer, Rodolphe BarrangouHuman Gene Therapy|March 31, 2026
AAV Vectors Have Limited Impact on Host Chromatin Accessibility and Nuclear ArchitectureJoël W Zöllig, Maija K Pietilä, Melina O Bräuer, et al.Human Gene Therapy|August 12, 2026
Real-World Data from a Single-Center, Large Academic Centralized Manufacturing of CD19 CAR T Cells in an Industry PartnershipKati Kebbel, Gerno Schmiedeknecht, Andrea Quaiser, et al.Human Gene Therapy|August 3, 2026
Adeno-Associated Virus-Mediated Central Nervous System Gene Transfer to Suppress Alzheimer's Disease High-Risk APOE4 Variant and Replace with Protective APOE2Kalpita R Karan, Neil R Hackett, Ronald G CrystalHuman Gene Therapy|September 11, 2026
Chimeric Antigen Receptor T Cell Targeting of Natural Killer Cells in Peripheral Blood and Tissues of Rhesus MacaquesTaylor M Oeschger, Benjamin Varco-Merth, Carly E Starke, et al.Human Gene Therapy|September 15, 2026
InsightRP2-An Interdisciplinary Approach Toward Therapy Development in RP2-Associated RetinopathyNina Bögershausen, Gökhan Yigit, Alisa Fedorenko, et al.Human Gene Therapy|October 26, 2026
A Modular Multilocus Engineering Platform for Iterative Prototyping of Oncolytic AdenovirusesZhoutong Dai, Hui Yu, Jiaqi Ye, et al.Human Gene Therapy|June 2, 2001
Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biologyA Belldegrun, C L Tso, A Zisman, et al.Human Gene Therapy|June 2, 2001
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitisP L Poliani, H Brok, R Furlan, et al.Pageof 414